Cargando…

A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer

Detalles Bibliográficos
Autores principales: Wang, Wei‐Da, Wu, Guo‐Yan, Bai, Kun‐Hao, Shu, Ling‐Ling, Chi, Pei‐Dong, He, Si‐Yuan, Huang, Xin, Zhang, Qian‐Yi, Li, Liang, Wang, Da‐Wei, Dai, Yu‐Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603297/
https://www.ncbi.nlm.nih.gov/pubmed/33135356
http://dx.doi.org/10.1002/ctm2.225
_version_ 1783603888526458880
author Wang, Wei‐Da
Wu, Guo‐Yan
Bai, Kun‐Hao
Shu, Ling‐Ling
Chi, Pei‐Dong
He, Si‐Yuan
Huang, Xin
Zhang, Qian‐Yi
Li, Liang
Wang, Da‐Wei
Dai, Yu‐Jun
author_facet Wang, Wei‐Da
Wu, Guo‐Yan
Bai, Kun‐Hao
Shu, Ling‐Ling
Chi, Pei‐Dong
He, Si‐Yuan
Huang, Xin
Zhang, Qian‐Yi
Li, Liang
Wang, Da‐Wei
Dai, Yu‐Jun
author_sort Wang, Wei‐Da
collection PubMed
description
format Online
Article
Text
id pubmed-7603297
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76032972020-11-05 A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer Wang, Wei‐Da Wu, Guo‐Yan Bai, Kun‐Hao Shu, Ling‐Ling Chi, Pei‐Dong He, Si‐Yuan Huang, Xin Zhang, Qian‐Yi Li, Liang Wang, Da‐Wei Dai, Yu‐Jun Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-10-31 /pmc/articles/PMC7603297/ /pubmed/33135356 http://dx.doi.org/10.1002/ctm2.225 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Wang, Wei‐Da
Wu, Guo‐Yan
Bai, Kun‐Hao
Shu, Ling‐Ling
Chi, Pei‐Dong
He, Si‐Yuan
Huang, Xin
Zhang, Qian‐Yi
Li, Liang
Wang, Da‐Wei
Dai, Yu‐Jun
A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title_full A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title_fullStr A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title_full_unstemmed A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title_short A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancer
title_sort prognostic stemness biomarker ccdc80 reveals acquired drug resistance and immune infiltration in colorectal cancer
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603297/
https://www.ncbi.nlm.nih.gov/pubmed/33135356
http://dx.doi.org/10.1002/ctm2.225
work_keys_str_mv AT wangweida aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT wuguoyan aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT baikunhao aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT shulingling aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT chipeidong aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT hesiyuan aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT huangxin aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT zhangqianyi aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT liliang aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT wangdawei aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT daiyujun aprognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT wangweida prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT wuguoyan prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT baikunhao prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT shulingling prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT chipeidong prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT hesiyuan prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT huangxin prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT zhangqianyi prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT liliang prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT wangdawei prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer
AT daiyujun prognosticstemnessbiomarkerccdc80revealsacquireddrugresistanceandimmuneinfiltrationincolorectalcancer